[go: up one dir, main page]

AU2017228675B2 - Cells useful for immuno-based Botulinum toxin serotype A activity assays - Google Patents

Cells useful for immuno-based Botulinum toxin serotype A activity assays Download PDF

Info

Publication number
AU2017228675B2
AU2017228675B2 AU2017228675A AU2017228675A AU2017228675B2 AU 2017228675 B2 AU2017228675 B2 AU 2017228675B2 AU 2017228675 A AU2017228675 A AU 2017228675A AU 2017228675 A AU2017228675 A AU 2017228675A AU 2017228675 B2 AU2017228675 B2 AU 2017228675B2
Authority
AU
Australia
Prior art keywords
botulinum toxin
immuno
toxin serotype
cells useful
activity assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017228675A
Other versions
AU2017228675A1 (en
Inventor
Ester Fernandez-Salas
D. Dianne Hodges
Birgitte P.S. Jacky
Joanne Wang
Hong Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010223910A external-priority patent/AU2010223910B2/en
Application filed by Allergan Inc filed Critical Allergan Inc
Priority to AU2017228675A priority Critical patent/AU2017228675B2/en
Publication of AU2017228675A1 publication Critical patent/AU2017228675A1/en
Application granted granted Critical
Publication of AU2017228675B2 publication Critical patent/AU2017228675B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS Abstract: The present specification discloses clonal celllines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines. H:\mm\Interwoven\NRPortbl\DCC\MM\7902079_1.docx - 10/6/15
AU2017228675A 2009-03-13 2017-09-15 Cells useful for immuno-based Botulinum toxin serotype A activity assays Active AU2017228675B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017228675A AU2017228675B2 (en) 2009-03-13 2017-09-15 Cells useful for immuno-based Botulinum toxin serotype A activity assays

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61/160,199 2009-03-13
AU2010223910A AU2010223910B2 (en) 2009-03-13 2010-03-12 Cells useful for immuno-based Botulinum toxin serotype A activity assays
AU2015203359A AU2015203359A1 (en) 2009-03-13 2015-06-11 Cells useful for immuno-based Botulinum toxin serotype A activity assays
AU2017228675A AU2017228675B2 (en) 2009-03-13 2017-09-15 Cells useful for immuno-based Botulinum toxin serotype A activity assays

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2015203359A Division AU2015203359A1 (en) 2009-03-13 2015-06-11 Cells useful for immuno-based Botulinum toxin serotype A activity assays

Publications (2)

Publication Number Publication Date
AU2017228675A1 AU2017228675A1 (en) 2017-10-05
AU2017228675B2 true AU2017228675B2 (en) 2019-11-14

Family

ID=53572166

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2015203359A Abandoned AU2015203359A1 (en) 2009-03-13 2015-06-11 Cells useful for immuno-based Botulinum toxin serotype A activity assays
AU2017228675A Active AU2017228675B2 (en) 2009-03-13 2017-09-15 Cells useful for immuno-based Botulinum toxin serotype A activity assays

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2015203359A Abandoned AU2015203359A1 (en) 2009-03-13 2015-06-11 Cells useful for immuno-based Botulinum toxin serotype A activity assays

Country Status (1)

Country Link
AU (2) AU2015203359A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009114748A1 (en) * 2008-03-14 2009-09-17 Allergan, Inc. Immuno-based botulinum toxin serotype a activity assays

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009114748A1 (en) * 2008-03-14 2009-09-17 Allergan, Inc. Immuno-based botulinum toxin serotype a activity assays

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Fernández-Salas E et al, "Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay", PLoS One, 2012, 7(11):e49516 doi: 10.1371/journal.pone.0049516. *
Marini P et al, "SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiation", Cancer Genetics and Cytogenetics, 1999, 112(2):161-164. *

Also Published As

Publication number Publication date
AU2017228675A1 (en) 2017-10-05
AU2015203359A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
MY175803A (en) Cells useful for immuno-based botulinum toxin serotype a activity assays
WO2010120785A3 (en) Methods and compositions for stem cell cultures
WO2010088633A3 (en) Novel cell lines and methods
WO2008154014A3 (en) A method for culturing mammalian cells to improve recombinant protein production
AU2009209251A8 (en) Stabilized Angiopoietin-2 antibodies and uses thereof
WO2010048417A3 (en) Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products
EP4296270A3 (en) A composition comprising stem cell cultures
WO2011133902A3 (en) Cell culture medium comprising small peptides
EA201390179A1 (en) NEW BACTERIA AND METHODS OF THEIR APPLICATION
EP4588519A3 (en) Immuno-based botulinum toxin serotype a activity assays
WO2013059293A9 (en) Single, direct detection of hemoglobin a1c percentage using enzyme triggered redox altering chemical elimination (e-trace) immunoassay
WO2007089677A3 (en) Systems and methods for producing biofuels and related materials
CO6351813A2 (en) "METHODS AND COMPOSITIONS TO IMPROVE THE PRODUCTION OF PRODUCTS IN MICROORGANISMS"
MX356756B (en) Pluripotent stem cell culture on micro-carriers.
MY181513A (en) Cell culture compositions and methods for polypeptide production
WO2006070370A3 (en) Stem cells culture systems
WO2009102569A3 (en) Cell lines and methods for making and using them
WO2008090770A1 (en) Microorganism capable of producing l-amino acid, and method for production of l-amino acid
NZ602201A (en) A novel ethanologenic clostridium species, clostridium coskatii
WO2007084677A3 (en) System and method for applying reduced pressure to cell culture
WO2008063675A3 (en) Endodermal progenitor cells
WO2012003402A3 (en) Compositions and methods for culturing microorganisms
WO2011014485A3 (en) Methods to characterize cell reprogramming and uses thereof
WO2012103261A3 (en) Compositions and methods for succinate production
WO2011085247A3 (en) Vectors and methods for transducing b cells

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

FGA Letters patent sealed or granted (standard patent)